Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (11,694,528) $ (8,078,768)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 69,352 55,672
Loss on disposal and abandonment of assets 64,833 19,962
Reserve for expiring inventory 133,006 0
Amortization of debt discount and issuance costs 126,878 0
Non-cash lease expense 91,733 91,456
Stock compensation expense 266,456 371,637
Gain on extinguishment of debt 0 (366,000)
Value of stock issued to 401(k) plan for employer matching contributions 44,720 76,846
Value of stock issued in payment of employee bonuses 24,847 0
Value of stock issued under long term incentive plan 19,740 0
Value of stock issued in payment of director fees 15,925 27,500
Changes in operating assets and liabilities:    
Receivables (62,197) (46,005)
Inventory (175,657) (9,137)
Prepaid expenses and other assets 953,566 507,225
Accounts payable 317,202 44,512
Accrued and other liabilities 2,727,010 35,161
Lease liabilities (266,970) (210,434)
Deferred revenue 790,644 (9,356)
Net cash used in operating activities (6,553,440) (7,489,729)
Cash flows from investing activities:    
Payments for purchases of equipment (63,086) (20,749)
Patent and trademark costs (255,224) (219,236)
Net cash used in investing activities (318,310) (239,985)
Cash flows from financing activities:    
Proceeds from issuance of preferred stock and warrants, including collection of stock subscriptions 6,173,000 12,682,700
Proceeds from issuance of common stock 0 2,135
Proceeds from note payable 2,500,000 0
Payment of debt issuance costs (14,627) 0
Principal payments on notes payable (453,427) (379,443)
Net cash provided by financing activities 7,241,676 12,235,430
Net increase in cash and cash equivalents 369,926 4,505,716
Cash and cash equivalents, beginning of period 4,230,865 2,670,495
Cash and cash equivalents, end of period 4,600,791 7,176,211
Preferred Stock Issuance Costs [Member]    
Cash flows from financing activities:    
Payment of stock issuance costs $ (963,270) $ (69,962)